M&A Deal Summary

Morgan Stanley Tactical Value Investing Acquires New Vision Pharmaceuticals

On January 1, 2018, private equity firm Morgan Stanley Tactical Value Investing acquired life science company New Vision Pharmaceuticals

Acquisition Highlights
  • This is Morgan Stanley Tactical Value Investing’s 1st transaction in the Life Science sector.
  • This is Morgan Stanley Tactical Value Investing’s 4th transaction in the United States.
  • This is Morgan Stanley Tactical Value Investing’s 2nd transaction in Florida.

M&A Deal Summary
Date 2018-01-01
Target New Vision Pharmaceuticals
Sector Life Science
Buyer(s) Morgan Stanley Tactical Value Investing
Deal Type Buyout (LBO, MBO, MBI)

Target

New Vision Pharmaceuticals

Tamarac, Florida, United States
New Vision Pharmaceuticals is a full-service FDA-registered contract development and manufacturing company. New Vision Pharmaceuticals is an experienced and reliable partner with a range of globally sourced raw materials at our disposal. New Vision Pharmaceuticals team of experts has extensive scientific knowledge in the pharmaceutical and dietary supplement industries that allows providing clients with a full range of services. New Vision Pharmaceuticals is based in Tamarac, Florida.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Morgan Stanley Tactical Value Investing

Investor Investor Investor Investor Investor

Category Private Equity Firm
PE ASSETS 1.4B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Morgan Stanley Tactical Value Investing is an opportunistic investment group within Morgan Stanley focused on flexible capital solutions across asset classes, sectors, and geographies. The group will consider a variety of investment solutions including preferred equity, asset-backed loans, recapitalizations, PIPEs, and junior/senior debt. Morgan Stanley Tactical Value Investing is headquartered in New York City.

DEAL STATS #
Overall 5 of 15
Sector (Life Science) 1 of 1
Type (Buyout (LBO, MBO, MBI)) 3 of 5
State (Florida) 2 of 3
Country (United States) 4 of 12
Year (2018) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-01 Unipharma

Tamarac, Florida, United States

Unipharma is a healthcare packaging business that assists pharma and nutraceutical companies in the development, manufacturing and packaging of liquid, disposable, single-dosage units using “blow-fill-seal” (BFS) technology. Unipharma is based in Tamarac, Florida.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-06-06 Dataminr

New York, New York, United States

Dataminr is an artificial intelligence (“A.I.”) platform detecting real-time, breaking news events for governments, corporates, financial firms and news agencies. Dataminr is based in New York city.

Buy -
Mergr

Product

Company

Legal